Convergence insufficiency and Parkinson's disease progression
Alba Herrero-Gracia1, Rosa Hernández-Andrés1, María José Luque1
1Department of Optics and Optometry and Vision Sciences, Faculty of Physics, Universitat de València, C/Doctor Moliner, 50, Burjassot, 46100, Valencia, Spain.
Parkinsonism & Related Disorders
|February 20, 2025
Summary
Convergence insufficiency (CI) is linked to Parkinson's disease (PD) progression. Vision assessments are crucial for managing CI and vergence deficits in PD patients.
Area of Science:
- Ophthalmology
- Neurology
- Neuroscience
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder impacting motor, sensory, and visual functions.
- Convergence insufficiency (CI) may serve as an early indicator of PD progression.
- Understanding the link between CI and PD stages is vital for patient management.
Purpose of the Study:
- To investigate the relationship between CI and PD stages using the Hoehn and Yahr scale.
- To compare CI prevalence and vision parameters in healthy individuals versus PD patients.
- To assess the correlation between advancing PD stages and the likelihood of CI.
Main Methods:
- A study involving 97 healthy controls and 71 PD patients.
- Medical history evaluations and comprehensive vision assessments were performed.
- Statistical analyses, including binary logistic regression, compared CI prevalence across PD stages.
Main Results:
- A significant increase in CI prevalence was observed in PD patients compared to controls, particularly in Stage III.
- CI prevalence escalated with advancing PD stages (p < .001).
- Logistic regression indicated a higher likelihood of CI with increased Hoehn and Yahr stage (p < .007).
Conclusions:
- A significant association exists between CI and PD progression.
- Standardized vision assessments are essential for managing CI in PD patients.
- Further longitudinal research is recommended to understand CI's role in PD progression.
Related Concept Videos
Parkinson's Disease: Overview
424
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
424
Parkinson's Disease: Treatment
185
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
185
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K


